Indian Erythromycin Exporters: Complete Supplier Ranking with Market Share — 368 Manufacturers (2026) — TransData Nexus

Q: Who is the largest erythromycin supplier from India?

MEDOPHARM is the largest erythromycin exporter from India with a 32.0% market share and export value of $25.5M.

Q: How many erythromycin suppliers are there in India?

There are 368 active erythromycin exporters in India, collectively shipping $79.7M worth of erythromycin across 3,939 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top erythromycin suppliers from India?

The top 5 erythromycin suppliers from India — MEDOPHARM, BDH INDUSTRIES LIMITED, LINCOLN PHARMACEUTICALS LTD, S KANT HEALTHCARE LIMITED, MEDREICH LIMITED — together control 48.9% of total erythromycin export value from India.

Suresh Sormare

Erythromycin

India Pharmaceutical Trade Intelligence

$79.7M368 Suppliers135 CountriesHS 30042061

ExportsIndia → AFGHANISTAN28.8%India → PHILIPPINES14.3%

ImportsBULGARIA → India$3.6M UNITED STATES → India$337.8K

#1 Supplier: MEDOPHARM

Erythromycin Suppliers from India (2026) — 368 Exporters, $79.7M Market | TransData Nexus | TransData Nexus

Who Exports Erythromycin from India — 368 Suppliers Behind a $79.7M Market

India's erythromycin export market is supplied by 368 active exporters who collectively shipped $79.7M across 3,939 shipments. MEDOPHARM leads with a 32.0% market share, followed by BDH INDUSTRIES LIMITED and LINCOLN PHARMACEUTICALS LTD. The top 5 suppliers together control 48.9% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Erythromycin Suppliers & Exporters — 368 manufacturers, $79.7M export market, top destinations and formulations — Erythromycin supplier data — 368 exporters · $79.7M market · 3,939 shipmentsTransData Nexus · Indian Customs Data

Top Erythromycin Exporters from India — Ranked by Export Value

MEDOPHARM is the leading erythromycin exporter from India, holding a 32.0% share of the $79.7M market across 3,939 shipments from 368 exporters. The top 5 suppliers — MEDOPHARM, BDH INDUSTRIES LIMITED, LINCOLN PHARMACEUTICALS LTD, S KANT HEALTHCARE LIMITED, MEDREICH LIMITED — collectively control 48.9% of total export value, indicating a competitive market. Individual shares are: MEDOPHARM (32.0%), BDH INDUSTRIES LIMITED (7.1%), LINCOLN PHARMACEUTICALS LTD (3.6%), S KANT HEALTHCARE LIMITED (3.5%), MEDREICH LIMITED (2.7%).

Top Erythromycin Exporters from India

Ranked by export value · 368 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Erythromycin Exporters from India — Ranked by Export Value. 368 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	MEDOPHARM

Erythromycin — Export Intelligence Video

Visual overview of India's erythromycin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's erythromycin pharmaceutical supplier landscape — $79.7M in total trade, 368 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Erythromycin exporters

Certification and compliance status for top Erythromycin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Cadila Pharmaceuticals Limited	Warning Letter, October 2	Yes, multiple facili	No	Not verified	Received FDA warning letter in October 2019 for violations at Moraiya and Ahmeda
Lincoln Pharmaceuticals Limited	Not Listed	Yes, certified in 19	Yes, certified	Not verified	Received EU GMP certification for Khatraj facility in May 2020.
Medopharm Private Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified as of 2025.
S Kant Healthcare Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified as of 2025.
Caplin Point Laboratories Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified in 2005.
Global Pharma Healthcare Private Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified as of 2025.
Medreich Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified as of 2025.
BDH Industries Limited	Not Listed	Yes, certified in 20	No	Not verified	WHO-GMP certified as of 2025.

TransData Nexus reviewed the regulatory standing of 8 leading Erythromycin exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 1 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Erythromycin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. This prominence is supported by a robust infrastructure that includes numerous bulk drug manufacturers and a skilled workforce. The city's pharmaceutical landscape is further enhanced by the Hyderabad Pharma City project, recognized as a National Investment Manufacturing Zone (NIMZ) in December 2019, underscoring its strategic importance.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, hosts a significant number of pharmaceutical companies, making it a major hub in the region. This cluster's emphasis on formulations complements the bulk drug production capabilities of other regions, contributing to a comprehensive pharmaceutical supply chain.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai's strategic coastal location and well-developed port facilities facilitate efficient international distribution. The region's pharmaceutical industry is characterized by a mix of established companies and emerging players, all benefiting from the logistical advantages and proximity to regulatory bodies.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Erythromycin exporters from India

October 26, 2025

M&A

Novartis — Novartis acquires Avidity Biosciences for $12 billion

Novartis announced an agreement to acquire U.S.-based biotech company Avidity Biosciences for approximately $12 billion in cash. This acquisition aims to expand Novartis's portfolio in rare muscle disorders, addressing significant unmet medical needs. IMPACT: This acquisition may lead to increased competition in the pharmaceutical sector, potentially affecting market dynamics for erythromycin exports.

Impact: This acquisition may lead to increased competition in the pharmaceutical sector, potentially affecting market dynamics for erythromycin exports.

April 2025

M&A

Johnson & Johnson — Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion

Johnson & Johnson completed the acquisition of Intra-Cellular Therapies, integrating the company into its Innovative Medicine division. This move adds CAPLYTA® (lumateperone), a treatment for bipolar I and II depression and schizophrenia, to Johnson & Johnson's portfolio. IMPACT: The expansion of Johnson & Johnson's neuroscience portfolio may shift focus within the pharmaceutical industry, indirectly influencing erythromycin market trends.

Impact: The expansion of Johnson & Johnson's neuroscience portfolio may shift focus within the pharmaceutical industry, indirectly influencing erythromycin market trends.

Common Questions — Erythromycin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which erythromycin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MEDOPHARM leads with 61 recorded shipments worth $25.5M. BDH INDUSTRIES LIMITED (17 shipments) and LINCOLN PHARMACEUTICALS LTD (11 shipments) are also established high-volume exporters.

Q How many erythromycin manufacturers are there in India?

India has 368 active erythromycin exporters with a combined export market of $79.7M across 3,939 shipments to 135 countries. The top 5 suppliers hold 48.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for erythromycin from India?

Average FOB unit price: $92.64 per unit, ranging from $0.01 to $89112.90. Average shipment value: $20.2K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Erythromycin

Erythromycin

Who Exports Erythromycin from India — 368 Suppliers Behind a $79.7M Market

Top Erythromycin Exporters from India — Ranked by Export Value

Top Erythromycin Exporters from India

Related Analysis

Need Details?

Erythromycin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Novartis — Novartis acquires Avidity Biosciences for $12 billion

Johnson & Johnson — Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion

Common Questions — Erythromycin Suppliers from India

Q Which erythromycin supplier from India is the most reliable for bulk orders?

Q How many erythromycin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for erythromycin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for targeted oncology expansion

Analysis Methodology